Repligen reported $554K in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agilent A:US $ 3M 0M
Align Technology ALGN:US $ 0.01M 0M
Bio Techne TECH:US $ 0.39M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Bruker BRKR:US $ 1.7M 0M
Catalent CTLT:US $ 2M 0M
Charles River Laboratories CRL:US $ 0.51M 0M
Danaher DHR:US $ 9M 0M
Exact Sciences EXAS:US $ 1.76M 0.02M
Fluidigm FLDM:US $ 0.08M 0M
General Electric GE:US $ 15M 0M
Henry Schein HSIC:US $ 1M 0.37M
Illumina ILMN:US $ 2M 0M
IQVIA Holdings Inc IQV:US $ 3M 0
Mettler Toledo International MTD:US 448K 0
Myriad Genetics MYGN:US $ 0.8M 0M
Nanostring Technologies NSTG:US $ 0M 0M
Orasure Technologies OSUR:US $ 0M 0M
Pacific Biosciences Of California PACB:US $ 0.22M 0M
Peregrine Pharmaceuticals PPHM:US $ 0.06M 0M
Perkinelmer PKI:US $ 126.14M 0.1M
Repligen RGEN:US $ 0.55M 0M
Thermo Fisher Scientific TMO:US $ 440M 1M
Waters WAT:US $ 1.62M 0M
West Pharmaceutical Services WST:US $ 18.8M 0M